RegenXBio's total assets for Q1 2025 were $490.93M, an increase of 5.35% from the previous quarter. RGNX total liabilities were $216.73M for the fiscal quarter, a 5.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.